CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (4,688)	$ 4,649
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation	6,272	4,786
Deferred income taxes	(804)	95
Amortizatoin of Financing Costs	74	74
Employee Benefits and Share-based Compensation	3,411	3,078
Impairment of fixed assets	7,200	0
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount	2,002	0
Change in accrual for unrecognized tax benefits	(18)	210
Gain (Loss) on Sale of Equity Investments	(200)	0
Loss on sale of business	0	537
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable	2,765	3,806
Prepaid expense and other assets	355	187
Capitalized contract costs	980	961
Accounts payable and accrued expenses	(4,242)	(7,546)
Income taxes receivable/payable	255	1,429
Deferred revenue	(4,041)	1,906
Other, net	699	203
Net cash flows from operating activities	10,020	14,375
Cash flows from (used in) investing activities:
Payments for (Proceeds from) Businesses and Interest in Affiliates	0	2,683
Payments for (Proceeds from) Investments	200	0
Purchases of fixed assets	(8,405)	(6,286)
Net cash flows from (used in) investing activities	(8,205)	(3,603)
Cash flows from financing activities:
Payments on long-term debt	(9,444)	(22,000)
Proceeds from long-term debt	36,444	14,000
Payments under stock repurchase plan	(5,076)	(491)
Purchase of treasury stock related to vested restricted stock	(1,523)	(1,050)
Net cash flows used in financing activities	20,401	(9,541)
Effect of exchange rate changes	(122)	(90)
Net change in cash and cash equivalents for the period	22,094	1,141
Cash and cash equivalents, beginning of period	5,381	6,472
Cash and cash equivalents, end of period	$ 27,475	$ 7,613